buspirone (Acrux)

N/A

Report date: 2026/01/22 16:41:54

Base Information

Drug Namebuspirone (Acrux)
Drug Alias Namebuspirone
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine modulatorsSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsAnxiety DisordersMyalgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAcrux
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcrux
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersMyalgia

Other Information

ATC CodeN/A
Related LinksN/A